Between 1917 and 1930, a neurological disease swept through the global population so silently that many doctors initially had no name for what they were seeing. Patients who had been healthy would begin to slow down, fall asleep mid-sentence, and spend entire days unconscious – yet could be briefly woken and would answer a question before drifting off again. Some went rigid. Some developed wild, involuntary movements. Some never woke up at all. The disease was encephalitis lethargica, and more than a century later, medicine still cannot say with certainty what caused it.
The scale of what happened between those years is staggering. More than one million people around the world were estimated to have been afflicted, and nearly 500,000 died from the disease. That death toll rivals many of the 20th century’s most feared epidemics, and yet encephalitis lethargica has remained, for most of the public, nearly invisible – overshadowed in history by the 1918 influenza pandemic that raged at the same time. With only a few sporadic cases diagnosed since the epidemic ended, the causes of this condition remain a medical mystery with very few clues.
The disease’s range of effects was extreme, the severity of its long-term damage profound, and the silence that followed its disappearance almost as strange as its arrival.
How Encephalitis Lethargica Was First Described
The clinical presentation typically began with non-specific prodromal symptoms such as headache, fever, and malaise. Severe sleep abnormalities would follow rapidly thereafter, consisting of extreme hypersomnia or insomnia, lasting several weeks. For the physicians observing this in the early 20th century, it looked like nothing they had catalogued before.
Acute encephalitis lethargica often presented as a gradual onset of flu-like symptoms, including low-grade fever, pharyngitis, shivering, headache, vertigo, and vomiting. Neurological symptoms followed and could present very quickly – as in the case of a girl who experienced a sudden hemiplegia while walking home from a concert. Within half an hour she was asleep, and died 12 days later.
Some patients presented with hypersomnia, spending all day asleep – they could be woken up but would return to sleep almost immediately. Others presented with hyperactivity and insomnia. These wildly divergent presentations made the disease nearly impossible to diagnose by a single consistent standard.
A 2024 paper in Brain Communications describes encephalitis lethargica as “an epidemic neurological illness” that “typically involved a severe sleep disorder and progressive parkinsonism.” To help physicians navigate the wide array of symptoms, neurologist Constantin von Economo classified acute encephalitis lethargica into three forms: somnolent-ophthalmoplegic (sleepiness combined with eye muscle paralysis), hyperkinetic (involving excessive, uncontrolled movement), and amyostatic-akinetic (involving loss of muscle tone and movement).
The somnolent-ophthalmoplegic form was the most common and typically developed soon after the onset of prodromal symptoms. Patients became dazed, confused, and delirious, and often exhibited features of mild meningeal irritation. Because there was no single definitive diagnostic test, encephalitis lethargica was diagnosed based on the exclusion of other conditions.
The Man Who Named It – and What the Disease Actually Did
Von Economo formally presented the disease to the Vienna Psychiatric Society in April 1917, at the height of the epidemic’s early spread. According to a 2015 review in Child’s Nervous System, encephalitis lethargica’s first evidence was presented by von Economo in April 1917, and his classification system remained the primary medical framework for understanding the condition for decades afterward.
Pathological studies revealed an encephalitis of the midbrain and basal ganglia, with lymphocyte infiltration – meaning inflammation of very specific brain structures. The basal ganglia (a group of brain regions deep in the brain that coordinate movement and behavior) and the midbrain were ground zero for the disease’s destruction. Over 50% of cases resulted in death, and survivors were often left with permanent mental or physical disabilities.
A post-acute illness often developed between one and five years after the initial infection, consisting of a slowly progressive parkinsonian disorder, sometimes with oculogyric crises (episodes where the eyes roll upward involuntarily) and florid neuropsychiatric symptoms.
In the largest encephalitis lethargica epidemic, lasting from 1917 to 1930, more than one million individuals around the world were affected. Although the disease affected all age groups, individuals between 10 and 45 years old were most susceptible, with 50% of cases occurring between ages 10 and 30. Motor symptoms appeared in roughly 98% of cases, cranial nerve problems in 91%, and sleep disorders in 66%. The sheer consistency of motor involvement gave researchers important clues about where in the brain the damage was concentrated – but did not tell them why.
The Survivors No One Remembered
Despite the scale of the epidemic, encephalitis lethargica all but disappeared from public consciousness after 1930. A significant portion of those who had survived the acute phase of the illness had not, in fact, recovered.
Approximately one-third of patients died during the acute phase of the illness, one-third survived without significant long-term damage, and one-third showed lasting neurological complications. For that final third, the story became quietly horrific. The 1973 publication of Awakenings by neurologist Oliver Sacks reminded the world that survivors of the big encephalitis lethargica epidemic were still alive and lying forgotten in the wards of chronic care hospitals. Surviving the original acute illness had turned into a new tragedy as severe post-encephalitic parkinsonism progressively engulfed patients, transforming them into living statues, preventing any communication with families and healthcare personnel.
The book details the effects of the drug L-DOPA, which allowed many patients to emerge from years of catatonia during a clinical trial in 1969. According to Proto Magazine’s account of Sacks’s work, Sacks treated a group of these patients at Beth Abraham Hospital, a long-term care facility in the Bronx, with L-DOPA. His patients awakened from their frozen states to act and move normally – but, as the same account notes, after a period of time the drug’s effects began to wear off, leaving them just as frozen inside their bodies as before.
Neurological diseases that reshape patients’ identities over decades through brain inflammation are not unique to encephalitis lethargica. The signs of Parkinson’s disease share telling overlaps with the post-encephalitic parkinsonism that Sacks documented – a connection that continues to inform modern neurodegenerative research.
The Spanish Flu Connection That Doesn’t Hold Up
For most of the 20th century, the assumed explanation was straightforward: encephalitis lethargica was a neurological consequence of the 1918 influenza pandemic. Both swept the globe simultaneously, striking overlapping populations at overlapping times.
Modern testing has made that assumption very hard to sustain. According to a 2004 study published in Brain by researchers at Great Ormond Street Hospital and University College London, von Economo and other contemporary scientists already believed the influenza virus was not the cause. Recent examination of archived encephalitis lethargica brain material has failed to demonstrate influenza RNA, adding to the evidence that the disease was not an invasive influenza encephalitis. This is a critical finding – if the flu virus had directly invaded brain tissue and caused the damage, traces of it should be detectable in preserved samples from patients who died during the epidemic. They aren’t.
That instinct, held by the disease’s own discoverer, has now been supported by molecular evidence. The two epidemics coincided; they were not the same event.
What Science Currently Suspects
If influenza didn’t cause encephalitis lethargica, what did? The 2024 Brain Communications paper notes that theories around infection, environmental toxins, catatonia, and autoimmune encephalitis have all been proposed, with no single explanation gaining definitive support.
The autoimmune hypothesis has attracted the most traction in recent years. The idea is that an unknown pathogen triggers the immune system, which then mistakenly attacks the brain itself – a process known as molecular mimicry, where antibodies produced to fight an infection end up targeting healthy tissue that resembles the pathogen.
The 2004 Great Ormond Street study published in Brain examined 20 new cases of encephalitis lethargica, mainly in children, finding that 95% had autoantibodies reactive against human basal ganglia antigens on western immunoblotting. In plain terms: nearly all of these patients’ immune systems were producing proteins that attacked the basal ganglia – the exact brain region destroyed during the epidemic. These antibodies were also present in the cerebrospinal fluid (the fluid surrounding the brain and spinal cord) in four of the patients tested. By contrast, antibodies reactive against the basal ganglia were found in only 2 to 4% of healthy children.
Research from 2024 published in the European Journal of Neurology indicates that encephalitis lethargica continues to occur sporadically, with findings in post-outbreak cases consistent with immune-mediated processes, suggesting it may represent an autoimmune spectrum disorder triggered by a viral agent such as a coronavirus. This framing shifts the disease from a single mysterious event to something potentially capable of being triggered again – by the right pathogen, in the right immune context.
The Matheson Commission, established in 1927 by businessman William Matheson after he was himself diagnosed with encephalitis lethargica, compiled data on more than 52,000 cases between 1919 and 1928 before being defunded in 1940 without having identified the responsible agent. The 1929 Matheson Report listed approximately 80 treatments that were tried during the epidemic – none of them reliably effective for treating acute encephalitis lethargica.
Why No One Has Found the Answer
A diagnosis of encephalitis lethargica still relies primarily on the elimination of other disorders. There is still no pathogen to identify, no confirmed antibody to test for, and no genetic marker or any other lab test to use for diagnosis. Doctors today face the same fundamental problem their predecessors faced in 1920.
Encephalitis lethargica is notoriously difficult to diagnose because the symptoms can resemble other conditions such as epilepsy, hysteria, drug intoxication, or psychiatric disorders. Patients are often referred to psychiatrists initially before the neurological cause is recognized.
According to a 2017 review published in Brain from researchers including those at University College London, among 59 reports of over 200 cases of encephalitis lethargica published between 1941 and 2009, only 14 reports seemed to fit the original diagnostic criteria – and it is impossible to be certain that any patient diagnosed with encephalitis lethargica today actually has the same syndrome that existed during the epidemic. The same review suggests encephalitis lethargica may have been a heterogeneous group of conditions – meaning not a single unified disease but a cluster of overlapping neurological syndromes – rather than a single entity. If true, that would partly explain why no single pathogen has ever been found: there may not be one.
As of 2024, reviews confirm fewer than 100 well-documented sporadic cases since the 1930s, with encephalitis lethargica-like presentations increasingly recognized as autoimmune encephalitides – conditions where the immune system attacks the brain, triggered by an infection that may have long since cleared.
What This Means Now
Medicine has, in a sense, moved on from encephalitis lethargica without ever solving it. The epidemic ended. Funding for research dried up as cases disappeared. The disease has never been definitively explained, which raises a practical question: could something like it happen again?
Without a known cause and a lack of cases to motivate funding, that question can’t be answered confidently in either direction. The autoimmune hypothesis offers the most actionable path forward: if a common viral trigger sets off an immune cascade that targets the brain, modern immunological tools – the kind that didn’t exist in 1920 – might eventually identify both the trigger and a way to interrupt the process.
Modern treatment approaches to encephalitis lethargica include immunomodulating therapies alongside treatments targeting specific symptoms, such as steroids and intravenous immunoglobulins. For the rare sporadic cases that appear today, that’s a meaningful step beyond what was available during the epidemic. It’s still treatment without a cure, for a disease without a confirmed cause. Over a century of investigation – including molecular analysis of preserved brain tissue from the epidemic period, the Matheson Commission’s massive data-gathering effort, and modern autoimmune research – has brought medicine considerably closer to understanding encephalitis lethargica. Closer, but not close enough. A disease that killed hundreds of thousands of people and paralyzed hundreds of thousands more has left behind no identifiable pathogen, no confirmed mechanism, and no reliable diagnostic test. That gap between the scale of what happened and the scarcity of what’s been explained remains one of the more unsettling open questions in the history of neurology.
Disclaimer: This information is not intended to be a substitute for professional medical advice, diagnosis, or treatment and is for information only. Always seek the advice of your physician or another qualified health provider with any questions about your medical condition and/or current medication. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.
Read More: What Is ‘Snowflake Disease’? The Symptoms You Need to Know